Navigation Links
SHAREHOLDER ALERT: Morgan & Morgan announces an investigation of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and whether senior management and the board of directors violated fiduciary duties owed to Vertex shareholders.
Date:11/27/2012

NEW YORK, Nov. 27, 2012 /PRNewswire/ -- Morgan & Morgan announces an investigation into whether certain officers and directors of Vertex breached their fiduciary duties to VRTX shareholders in connection with Vertex's recent public acknowledgement that it made inaccurate disclosures about the Phase 2 clinical studies of VX-909 and Kalydeco, two experimental drugs in clinical trials.  No decision to file a lawsuit has been made.  If you are a current shareholder of Vertex Pharmaceuticals and are interested in learning more about our Vertex (VRTX) shareholder lawsuit investigation, please contact George Pressly, Esq. at 1 (800) 631-6234 or email George at info@morgansecuritieslaw.com.

On May 7, 2012, Vertex issued a press release claiming that patients who received VX-909 and Kalydeco during a phase 2 clinical trial showed significant improvement in their lung functions. Published reports state that between May 7, 2012 and May 25, 2012, certain Vertex officers and directors sold over $22 million of their personally owned shares. On May 29, 2012, Vertex acknowledged publicly that the results from its clinical trials were not as positive as previously indicated. On June 27, 2012 Vertex admitted that the May 7th statements were simply inaccurate.   Vertex's stock price declined significantly on the news.

About Morgan & Morgan
Morgan & Morgan is one of the nation's largest 200 law firms. In addition to securities law, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability.  All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the p
'/>"/>

SOURCE Morgan & Morgan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. OncoSec Medical Issues Letter to Shareholders
2. Faruqi & Faruqi, LLP is Investigating Pain Therapeutics Inc. on Behalf of its Shareholders (PTIE)
3. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
4. Ampios CEO and CSO Send Message to Shareholders
5. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
6. Sinovac Schedules 2012 Annual Meeting of Shareholders
7. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
8. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
9. Carl Icahn Issues Open Letter to Shareholders of Forest Laboratories
10. AMRI Renews Shareholder Rights Plan
11. AspenBio Pharma to Provide Shareholders with Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... UNICANCER pourra identifier ... bénéficier de l,innovation thérapeutique.   ... contenu pour l,Entreprise, annonce que sa solution Luxid® ... de lutte contre le cancer (CLCC), comme module ... (Continuum Soin-Recherche) conduit par la société de conseil ...
(Date:3/5/2015)... 5, 2015  Pfenex Inc. (NYSE MKT: PFNX), ... of biosimilar therapeutics including high value and difficult ... quarter and full year 2014 financial results will ... the market opens for trading.  At 9:00 am ... call to discuss the financial results and provide ...
(Date:3/5/2015)... 2015  IRIDEX Corporation (Nasdaq: IRIX ) today ... January 3, 2015.  , Revenues were $11.8 million ... Company and up 11% from $10.6 million in the 2013 ... record, up 12% from $38.3 million in 2013. , ... from 48.6% in the fourth quarter of the prior year. ...
Breaking Medicine Technology:TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 2TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 3TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 4Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8
... Hanger Orthopedic Group, Inc. (NYSE: HGR ) ... operations for the quarter ended September 30, 2010, on Wednesday, ... a press release announcing the results for the quarter ended ... close of the market. The conference call is scheduled to ...
... Sept. 30 /PRNewswire-FirstCall/ - Neuro-Biotech Corporation (PINKSHEET: MRES)(OTCQB:MRES) in ... on SymPath(R) and is now ready to give you ... of the Sympathetic Nervous System (SNS). Here is a ... will be available to all patients through their health ...
Cached Medicine Technology:Hanger Orthopedic Group, Inc. Announces Third Quarter 2010 Earnings Release Conference Call 2A brief explanation of Dopamine-Beta-hydroxylase (DBH) - SymPath(R) : In Vitro Diagnostic Test to distinguish anxious disorders from depressive disorders 2A brief explanation of Dopamine-Beta-hydroxylase (DBH) - SymPath(R) : In Vitro Diagnostic Test to distinguish anxious disorders from depressive disorders 3
(Date:3/6/2015)... California (PRWEB) March 06, 2015 Johnson ... million jury verdict on March 5, 2015 in Superior ... According to court documents, a jury of 12 awarded ... suffered from being implanted with an Ethicon TVT Abbrevo ... nine men and three women also awarded $5 million ...
(Date:3/6/2015)... First Choice Emergency Room opened its new Littleton ... 13351 W. Bowles Avenue, Littleton, Colorado and is open 24-7. ... provide the highest quality emergency medical care to the Littleton ... Emergency Room Littleton. , First Choice Emergency Room ... of Commerce and a medical community open house yesterday. ...
(Date:3/6/2015)... 2015 Jvion, the Atlanta-based leader ... a Clostridium Difficile (C Diff) predictive use case ... use case is the latest in a broad ... infections, chronic conditions, and individual illnesses. Using the ... solution flags at risk individuals to help support ...
(Date:3/6/2015)... Truly Nolen, the largest family-owned pest control ... opening of their first independently-owned and operated franchise in ... Fort Mill – Rock Hill, SC area. The ribbon ... their new location. , The Truly Nolen ... in the pest control industry. Locally owned and operated ...
(Date:3/6/2015)... 2015 In a new study conducted at ... reported that shoulder pain was their first mesothelioma symptom. Surviving ... Click here to read it now. , Doctors ... records of 49 mesothelioma patients between 2006 and ... was shoulder pain that first prompted them to see a ...
Breaking Medicine News(10 mins):Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:First Truly Nolen Franchise Opening in North Carolina 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2
... was supported by the German Research Foundation, brought together scientists ... from the Charit in Berlin. 28 younger persons who had ... equal number of non-smokers participated in this study. Each of ... faces while their brain activity was recorded. The researchers were ...
... logic. But although a computer processor can be dissembled and ... the way our brains process information, says Mark Shein of ... Shein and his supervisors, Prof. Yael Hanein of the School ... of Physics and Astronomy, want to understand the brain,s logic. ...
... has released its global status report on alcohol and ... the discussion in the report of the serious health ... which contributes to accidents, many diseases, and premature deaths. ... that the report was limited almost exclusively to abusive ...
... By Steven Reinberg HealthDay Reporter , MONDAY, July ... comes new research pitting fast food against fruits and veggies, ... found that so-called "food deserts," where there are few or ... to draw locals to the fast food. But in areas ...
... -- Upward social mobility appears to help reduce the risk ... poor or disadvantaged situations, according to a new study. ... at increased risk for high blood pressure, which contributes to ... and socioeconomic data collected from 12,000 same-sex twins who were ...
... presented at the upcoming annual meeting of the Society ... society for research into all aspects of eating and ... promote overeating, weight gain, and insulin resistance. Olanzapine, ... the treatment of schizophrenia and bipolar disorder, has been ...
Cached Medicine News:Health News:Smokers not very receptive to shocking images 2Health News:Cracking the code of the mind 2Health News:Cracking the code of the mind 3Health News:Fast Food Is King of the Neighborhood, Study Reports 2Health News:Fast Food Is King of the Neighborhood, Study Reports 3
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Gold radiopaque markers indicate the proximal and distal ends of the balloon. Supplied sterile in peel-open packages. Intended for one-time use....
... balloon design allows the ureter to be ... marker at the base of the balloon ... ureteral dilation. Supplied sterile in peel-open packages. ... Vise Handle (plastic), Straight Safety Wire Guide ...
Used retrograde to dilate the ureter and establish a conduit for a flexible ureteroscope. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: